Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Buy
96
+21
+28% +$4.02K ﹤0.01% 391
2026
Q1
$13K Buy
75
+3
+4% +$553 ﹤0.01% 414
2025
Q4
$12K Sell
72
-1
-1% -$163 ﹤0.01% 437
2025
Q3
$10K Sell
73
-1
-1% -$135 ﹤0.01% 472
2025
Q2
$9K Buy
74
+53
+252% +$6.6K ﹤0.01% 491
2025
Q1
$3K Hold
21
﹤0.01% 622
2024
Q4
$3K Buy
21
+9
+75% +$1.52K ﹤0.01% 620
2024
Q3
$2K Sell
12
-4
-25% -$837 ﹤0.01% 656
2024
Q2
$3K Buy
16
+14
+700% +$3.04K ﹤0.01% 543
2024
Q1
$1K Buy
+2
New +$468 ﹤0.01% 859
2023
Q4
Sell
-13
Closed -$2K 1086
2023
Q3
$2K Sell
13
-3
-19% -$802 ﹤0.01% 455
2023
Q2
$4K Buy
+16
New +$4.76K ﹤0.01% 367

Other funds holding BIIB

Avion Wealth's BIIB Position: Q2 2026 in Review

Avion Wealth increased its Biogen (BIIB) stake by 28% in Q2 2026, buying an estimated $4.02K and bringing the position to 96 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Avion Wealth first reported a position in BIIB in Q2 2023 and has held it in 12 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Avion Wealth held 96 shares of Biogen worth $20K as of Q2 2026.
  • Avion Wealth bought 21 Biogen shares in Q2 2026, an estimated $4.02K.
  • Biogen made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #391 holding.
  • Avion Wealth first reported a position in Biogen in Q2 2023 and has held it in 12 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.